February 8, 2018. Companies that make and install synthetic turf on these types of surfaces maintain that it is proven safe and cost-effective compared to grass. However, these materials are not required by any federal government agency to be proven safe. These surfaces can expose children to harmful chemicals and can put children at risk of injury. We appreciate the Committee’s close attention and legislative oversight of this important safety issue for our state’s children and their schools.
Read More »On Health Policy
NCHR and WomenHeart Comments on USPSTF Draft Recommendation Statement Cardiovascular Disease Risk: Screening with Electrocardiography (ECG)
Jan 22, 2018, We commend the USPSTF for reviewing the evidence and developing evidence-based recommendations. There is substantial evidence to recommend against screening in low risk adults and is insufficient to support screening in higher risk adults.
Read More »NCHR Comments on the FDA’s Opioid Public Steering Committee (OPSC)
December 21, 2017. We applaud the FDA for addressing their role in developing strategies to “confront” the opioid crisis. We agree that the magnitude and scope of this crisis requires urgent action and agree that the FDA should consider patients’ and other relevant groups’ interests in developing effective approaches to reduce further harm from opioids.
Read More »Letter to Zoetis to Concerning Antibiotics for Food-Producing Animals
December 15, 2017. Organizations urge Zoetis to request voluntarily that the Food and Drug Administration (FDA) withdraw the approval for use in food-producing animals of Zoetis products that contain drugs in the polymyxin class.
Read More »Letter to Ramaswamy at USDA NIFA on Funding for Research on Antibiotic Resistance
December 15, 2017. We ask that NIFA continue to support research into antibiotic resistance at least at the current levels and specifically include antibiotic resistance among the areas to be funded as part of the AFRI requests for applications for FY2018.
Read More »